Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction.

about

Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction.

Item

http://www.wikidata.org/entity/Q51754955

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@en

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@nl

type

Item

label

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@en

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@nl

prefLabel

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@en

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@nl

P1476

Sofosbuvir-based regimens for ...... C in severe renal dysfunction.

@en

P2093

Charles S Landis

http://www.w3.org/2001/XMLSchema#string

Kelsey L Hawkins

http://www.w3.org/2001/XMLSchema#string

Marie N Hawley

http://www.w3.org/2001/XMLSchema#string

Paula Cox-North

http://www.w3.org/2001/XMLSchema#string

Renuka Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Sean T Rossiter

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.

Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Healthcare workers and prevention of hepatitis C virus transmission: exploring knowledge, attitudes and evidence-based practices in hemodialysis units in Italy

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.

The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.

P304

248-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP4.1035

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404457

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

5721450

http://www.w3.org/2001/XMLSchema#string